Peer Review History
| Original SubmissionAugust 14, 2024 |
|---|
|
Dear Dr. O'Brien, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 18 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Xiangwei Li Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that your Data Availability Statement is currently as follows: [All relevant data are within the paper and its Supporting information files.] Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Thank you to the authors for this considered and comprehensive manuscript that will add value to the field of HIV disability and rehabilitation. My feedback is provided below: 1) Line 91 data point 0.32, this may not be fully intuitive to the reader therefor may require either some context or explanation of what 0.32 additional functional limitation means. 2) Line 97 single aspect of disability may not be understood by some readers, therefore please consider expanding eg: only mental and emotional impairments. 3) Lines 142-143, the single summary score may not be known as an original feature of the full HIV Disability Questionnaire (HDQ), therefore it is unclear why this information is included in the description of the SF-HDQ. Please can you explain what the relevance of not having tyhe summary score is, to rationalise including this sentence. 4) Figure 1: There is not consistency in group presentation eg: [A] presents in order medium, low, high, but [C] presents low, medium, high. Can all figures in figure 1 be presented in the same order from low to high as described in lines 256-259? 5) Are high and high-declining trajectories (line 258) the same or different, as high implies a stable trajectory compared to high-declining. 6) I am unclear from the trajectories describe over 8 months, if this dopes or does not include the episodic or fluctuating nature of disability over this time frame. In the results (lines 267-287), can people transition between trajectories? 7) For participants who reported good or bad days, is the data presented for bad days at any time point? (line 286) and does this reflect an episodic change during a trajectory? 8) I am not clear on the significance or value of 3 versus 4 trajectories between differing dimensions (lines 340-344). Can this be discussed eg: in discussion paragraph lines 386-395? 9) Lines 362-364, could the concept of "triaging" trajectories assist in describing the provision of person-centred care. 10) Line 353 there is the opportunity to include additional disability prevalence data eg: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0267271 11) The discussion of associations between extrinsic and intrinsic conceptual factors and disability severity across dimensions would benefit from including data form existing literature eg: "Participants who were diagnosed with HIV late, were economically inactive, received benefits, and received rehabilitation in past 12-months were associated with statistically significant increased odds for severe disability" https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0267271 12) Grammar suggestion (line 446) please consider adjusting to "interventions, services and policies aimed at preventing or mitigating disability to improve health health outcomes among adults aging with HIV" Reviewer #2: In this manuscript, the authors address a crucial gap in the literature looking at disability trajectories among older adults living with HIV, using a multidimensional definition for disability. Overall the manuscript is well written and technologically sound. The authors incorporate several important contextual factors (both modifiable and non-modifiable) to help contextualize differences in disability trajectories overtime. The findings are limited by a relatively short follow up period (8 months) which may explain why most of the "trajectories" are stable over time. A few considerations are outlined below to help improve the clarity of the work: 1. Ensure there is consistency in how things are labeled in Table 1 (i.e. gender is follow by (n) but race/ethnicity is not) and organized in Figure 1 (i.e. use the same order for presenting trajectory groups across domains such as Low, followed by Medium, followed by High). 2. In the results section where authors describe % of participants in various disability groups (starting on line 267) it is a bit confusing when certain groups are being referred to as "consistently low level of disability" (line 268) vs others as "low disability trajectory" (line 275) when both trajectories look very similar on in Figure 1. It makes it sound like there is a difference between the two (the former staying the same over time while the latter declining). Perhaps using the same language consistently would help avoid this confusion, i.e. calling both trajectories. 3. Was there a correlation between disability trajectory group assignment across domains of disability? For example, are those assigned to the high physical symptoms trajectory group more likely to also be in the high challenges to social inclusion trajectory? 4. How was good vs. bad day assignment taken into account in the analysis? ********** ********** |
| Revision 1 |
|
Dear Dr. O'Brien, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 14 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Stanley Chinedu Eneh Academic Editor PLOS ONE Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #3: Yes ********** Reviewer #1: All comments via peer review have been fully considered and addressed by the study authors. The paper is suitable for publication and will add value to the literature base in the field of HIV, disability and rehabilitation. Reviewer #3: This is a strong and good manuscript that effectively communicates the purpose, methods, key findings, and implications of the research. It is well-suited for a scientific audience and clearly demonstrates the value of the study. The methodology is sophisticated and appropriate for the research questions. By incorporating more descriptive language for the trajectories and using stronger, more causal language to describe the associations, the authors can elevate an already excellent abstract to be even more compelling and informative. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 2 |
|
Trajectories of disability and influence of contextual factors among adults aging with HIV: insights from a community-based longitudinal study in Toronto, Canada PONE-D-24-33533R2 Dear Dr. O'Brien, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Stanley Chinedu Eneh Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-33533R2 PLOS ONE Dear Dr. O'Brien, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Stanley Chinedu Eneh Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .